Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionAIA Group Ltd
Latest Disclosed Ownership27,962 shares
Latest Disclosed Value $ 9,838,430
AIA Group Ltd reports 11.19% increase in ownership of AMGN / Amgen Inc.

On May 6, 2026 - AIA Group Ltd filed a 13F-HR form disclosing ownership of 27,962 shares of Amgen Inc. (MX:AMGN) valued at $9,838,430 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 25,147 shares of Amgen Inc.. This represents a change in shares of 11.19% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F AMGEN COM 031162100 27,962 2,815 11.19 9,838 19.54 0.1430
2026-02-09 2025-12-31 13F AMGEN COM 031162100 25,147 3,271 14.95 8,231 33.32 0.1232
2025-12-18 2025-09-30 13F AMGEN COM 031162100 21,876 8,341 61.63 6,173 63.35 0.1091
2025-08-06 2025-06-30 13F AMGEN COM 031162100 13,535 12,122 857.89 3,779 758.86 0.0822
2025-05-12 2025-03-31 13F AMGEN COM 031162100 1,413 1,413 440 0.0108
2024-10-31 2024-09-30 13F AMGEN COM 031162100 0 -1,645 -100.00 0 -100.00
2024-07-31 2024-06-30 13F AMGEN COM 031162100 1,645 -508 -23.59 514 -16.18 0.0150
2024-05-06 2024-03-31 13F AMGEN COM 031162100 2,153 2,153 612 0.0200
2023-07-28 2023-06-30 13F AMGEN COM 031162100 0 -8,469 -100.00 0 -100.00
2023-04-28 2023-03-31 13F AMGEN COM 031162100 8,469 -1,261 -12.96 2,047 -19.88 0.1110
2023-01-31 2022-12-31 13F AMGEN COM 031162100 9,730 5,343 121.79 2,555 158.34 0.1557
2022-11-04 2022-09-30 13F AMGEN COM 031162100 4,387 -2,704 -38.13 989 -42.67 0.0648
2022-08-11 2022-06-30 13F AMGEN COM 031162100 7,091 4,153 141.35 1,725 142.96 0.0926
2022-05-06 2022-03-31 13F AMGEN COM 031162100 2,938 845 40.37 710 50.74 0.0249
2022-02-11 2021-12-31 13F AMGEN COM 031162100 2,093 332 18.85 471 25.94 0.0222
2021-11-05 2021-09-30 13F AMGEN COM 031162100 1,761 -4 -0.23 374 -14.02 0.0211
2021-08-03 2021-06-30 13F AMGEN COM 031162100 1,765 -669 -27.49 435 -28.22 0.0299
2021-05-14 2021-03-31 13F AMGEN COM 031162100 2,434 806 49.51 606 56.99 0.0875
2021-02-12 2020-12-31 13F AMGEN COM 031162100 1,628 1,628 386 0.0445
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.